Abstract. Apoptosis of osteoblasts has been proposed as the common basis of osteoporosis, with oxidative stress as the major cause. This study was performed to investigate the protective effect of simvastatin (0.001-0.1 µM) on 100 µM hydrogen peroxide (H 2 O 2 )-mediated oxidative stress-induced apoptosis in human osteosarcoma (MG63) cells and the molecular mechanisms involved. Cell apoptosis was evaluated by observation of morphological changes and Annexin V-propidium iodide double staining followed by flow cytometric analysis. MTS assays were used to evaluate cell viability. To investigate the underlying molecular mechanisms, the expression of caspase-3, caspase-9 and Bcl-2 were analyzed by Western blotting. Following stimulation with H 2 O 2 for 24 h, a high proportion of MG63 cells underwent apoptosis, while a dosedependent inhibition of apoptosis was observed in the presence of simvastatin. A significant, dose-dependent reduction in the expression of caspase-3 and caspase-9 protein induced by H 2 O 2 in MG63 cells was observed in response to simvastatin and the Bcl-2 levels were increased. In conclusion, simvastatin protects MG63 cells from oxidative stress-induced apoptosis through downregulation of caspase-3 and caspase-9 activation and upregulation of Bcl-2 expression, suggesting a protective effect in osteoporosis.
Introduction
Osteoporosis has been defined as a systemic skeletal disease characterized by gradual loss and microarchitectural deterioration of bone tissue, resulting in increased bone fragility and susceptibility to fracture (1) . Osteoblasts are responsible for bone formation while osteoclasts are involved in bone resorption. Conditions such as postmenopausal osteoporosis are associated with significant changes in bone turnover; bone formation decreases and bone resorption increases or remains the same, resulting in net bone loss (2, 3) .
Oxidative stress, resulting from excessive levels of reactive oxygen species (ROS), represents a major cause of cellular damage and death in a plethora of pathological conditions, including osteoporosis. This is associated with distinct increases in blood levels of oxidative stress markers (4) (5) (6) . The main oxygen species responsible for oxidative stress are hydrogen peroxide (H 2 O 2 ), the free radical superoxide anion (O 2 - ) and the hydroxyl radical (OH -). Osteoblasts produce antioxidants such as glutathione peroxidase that protect against ROS (7) and osteoclast-generated superoxide contributes to bone degradation (8) . In ovariectomized rats, a model of postmenopausal osteoporosis, increased levels of lipid peroxidation and H 2 O 2 and decreased levels of enzymatic antioxidants were detected in tissue homogenates from the femora (9) . Furthermore, antioxidant enzyme GPX1 gene polymorphisms are associated with low bone mineral density (BMD) and increased bone turnover markers (10) .
The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-COA) reductase inhibitor, simvastatin, is a widely used cholesterollowering drug that inhibits hepatic cholesterol biosynthesis. Recent studies have shown the beneficial effects of statins on BMD (11, 12) . It has been suggested that a number of statin drugs, including simvastatin, increase the mRNA expression of bone morphogenetic protein 2 (BMP-2) in osteoblasts and are involved in promoting osteoblast differentiation with a subsequent increase in bone formation, when injected subcutaneously over the murine calvaria (13) . Numerous animal and human studies have been performed to elucidate the clinical importance of statins. The majority of experimental and epidemi ological studies have shown statins to have beneficial effects on bone metabolism, as evaluated by BMD (14) (15) (16) and fracture risk (17) (18) (19) . Statins have therefore been proposed as potential agents in the treatment of osteoporosis.
The MG63 human osteogenic sarcoma cell line is widely studied as a typical example of human osteoblast-like cells (20, 21 , 100 U/ml penicillin and 100 µg/ml streptomycin, in a humidified 5% CO 2 atmosphere at 37˚C. The cells were passaged every 3 days. MG63 cells were seeded at a density of 2x10 6 cells/dish in 100-mm dishes in DMEM with 2% calf serum. Confluent cell cultures were incubated in the presence or absence of simvastatin (0, 0.001, 0.01 and 0.1 µM) for 2 h followed by stimulation with 100 µM H 2 O 2 and further incubation for 24 h. MG63 cells were observed for morphological changes.
Flow cytometric analysis. Recovery of cells was monitored by examination of the levels of apoptosis 24 h following H 2 O 2 treatment. Annexin V binding and propidium iodine (PI) staining were determined by flow cytometry. Cells were treated with 100 µM H 2 O 2 for 24 h, washed with ice-cold PBS and double-stained with FITC-conjugated Annexin V protein and PI for 20 min. Flow cytometry was performed with a 488-nm laser coupled to a cell sorter (FacsCalibur; BD Biosciences, San Jose, CA, USA). Cells stained with PI and Annexin V were considered necrotic, while cells stained only with Annexin V were considered apoptotic.
MTS assay. MG63 cells (5,000 cells/well) were seeded in 96-well microtiter plates. Following incubation with 0.001, 0.01 and 0.1 µM simvastatin for 2 h, cells were treated with 100 µM H 2 O 2 for a further 24 h. Subsequently, 20 µl MTS solution was added to each well, and the plates were incubated for 3 h at 37˚C. The absorbance was measured at 490 nm and used to calculate the relative ratio of cell viability.
Western blot analysis. Protein expression of activated caspase-3, caspase-9 and Bcl-2 was analyzed by Western blotting. Cytoplasmic extracts were prepared in lysis buffer containing 150 mM NaCl, 10 mM Tris-HCl (pH 7.9), 0.5% Triton X-100, 0.6% NP-40, and protease inhibitors, 1 mg/ml leupeptin, 1 mg/ml pepstatin A and 2 mg/ml aprotinin. Protein content was determined using a detergent compatible (DC) protein assay kit (Bio-Rad, Richmond, CA, USA). Protein (40 µg mixed with 2X SDS sample buffer) was separated by 10% polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA, USA) prior to incubation for 2 h in blocking buffer (PBS with 7.5% non-fat dry milk, 2% BSA, 0.1% Tween). Active caspase-3, caspase-9 and Bcl-2 proteins were detected by incubation with appropriate primary antibodies (1:400 in blocking buffer) overnight at 4˚C. Subsequently, membranes were washed (PBS with 0.1% Tween-20) and incubated with peroxidase-conjugated goat anti-rabbit IgG (Pierce, 1:10000 dilution in blocking buffer) for 1 h at room temperature. Membranes were then washed in PBS and developed using the enhanced chemiluminescence (ECL) detection system (Amersham Biosciences, Uppsala, Sweden).
Statistical analysis.
All experiments were performed on three or more occasions and results are expressed as the mean ± SD. Statistical significance was analyzed by one-way analysis of variance (ANOVA) and p<0.05 was considered to be statistically significant. (Fig. 3) . Significantly decreased viability was observed by MTS assay in MG63 cells treated (Fig. 4) .
Results

Selection of conditions for simvastatin and
Simvastatin prevented H 2 O 2 -induced downregulation of Bcl-2 and upregulation of caspase-3 and caspase-9 activation.
The mechanism underlying the observed protective effects of simvastatin on MG63 cells against H 2 O 2 -induced apoptosis was investigated by analysis of the cleaved form of caspase-3 (17 kDa), caspase-9 (37 kDa) and Bcl-2 (28 kDa) by Western blot analysis. Simvastatin at concentrations >0.001 µM significantly upregulated the protein expression of caspase-3 and caspase-9 in MG63 cells following 24 h of H 2 O 2 treatment and prevented H 2 O 2 -induced downregulation of Bcl-2. A direct correlation was observed between the magnitude of this effect and the concentration of simvastatin (Fig. 5) .
Discussion
ROS are free radical-containing molecules derived from oxygen and its products. Recent studies have reported increased ROS as a significant factor in the occurrence of senile, postmenopausal and other types of primary osteoporosis (6, 22) . A negative correlation has been reported between the level of oxidative stress and bone density in the elderly (6) . Related data showed that ROS promoted activation of osteoclast and bone resorption (23) , and inhibited proliferation and differentiation of osteoblasts (24) . In this study a dose-dependent reduction in viability was detected by MTS assay in cells treated with increasing concentrations of H 2 O 2 for 24 h. Based on these observations cells were treated with 100 µM H 2 O 2 in subsequent experiments. Statins are 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-COA) reductase inhibitors, widely used in the clinic for regulation of cholesterol levels in the blood. In recent years, statins have been shown to stimulate osteoblast proliferation in vitro, and to promote new bone formation in the skull and os integumentale of newborn rats (13) . Statins stimulate increased expression of the BMP-2 gene in osteoblasts, and simvastatin has been suggested to activate the protein kinase pathway and resist the inhibitory action of TNF-α on BMP-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho mitosis (25, 26) . Statins are associated with a variety of other activities including induction of osteoblast differentiation (27) , resistance of the inhibitory effects on osteoblast growth and enhancement of osteoclast activity induced by IL-1, IL-6, TNF-α and other inflammatory factors (28), inhibition of matrix metalloproteinase activity (29) , upregulation of vascular endothelial growth factor (VEGF) (30) , enhanced activity of endothelial nitric oxide synthase (eNOS) (31) and inhibition of differentiation of adipose cells from multipotential stem cells (32) .
In this study, no significant differences in the growth and cytotoxicity of MG63 cells in the simvastatin-treated groups (0.001, 0.01, 0.1, 1, and 10 µM) were observed compared to those of the control group. Simvastatin doses of 0.001, 0.01, and 0.1 µM were chosen as the experimental model conditions, which was in accordance with the conventional C max dose (ng/ ml) used in the clinic. Observation of cell morphology and viability revealed that the proportion of apoptotic cells induced by H 2 O 2 decreased with increasing simvastatin concentration. Similarly, flow cytometric data confirmed simvastatin-associated inhibition of MG63 cells apoptosis induced by H 2 O 2 . It may be speculated that these protective effects contribute to the antioxidant activity of this drug. Apoptosis progresses via a series of complex procedures regulated by caspases, which are a group of proteases known as apoptosis effectors (33) . Caspases are activated by three main activation pathways: the mitochondrial (34), death receptor (35) and endoplasmic reticulum pathways (36) . Activation of caspase-9, the most upstream protease in the mitochondrial pathway is particularly significant in activation of the whole endogenous apoptosis pathway. Following release from mitochondria, cytochrome c combines and activates apoptotic protease activating factor 1 (Apaf-1) in a deoxyadenosine triphosphate (dATP)-dependent process. Activated Apaf-1 combines with and activates caspase-9 proenzyme, which cleaves the caspase-3 proenzyme to produce the activated caspase-3 tetramer (37), which is the most critical effect protease (38) .
Bcl-2 functions as a key regulator of apoptosis by modulation of mitochondrial function (39) . ROS increase mitochondrial permeability, resulting in cytochrome c release. Bcl-2 family member proteins regulate the release of mitochondrial cytochrome c during oxidative stress in MG63. Cell survival is enhanced when Bcl-2 expression is relatively high. Caspases are downstream of the Bcl-2 family in the apoptotic cascade. Pro-caspase-3 is cleaved by active caspase-9 to active caspase-3, which along with caspases-6 and -7 are 'executioner' caspases, which activate a DNase responsible for the fragmentation of oligonucleosomal DNA. In this study simvastatin was shown to upregulate H 2 O 2 -induced expression of Bcl-2 with concomitant downregulation of active caspase-9 expression and delayed reduction in caspase-3 activation. These results indicated that the anti-apoptotic effect of simvastatin was due to mitigated H 2 O 2 stress-induced mitochondrial dysfunction.
In conclusion, this study demonstrated that simvastatin rescues MG63 cells from H 2 O 2 -induced cell death, and that this protective effect is related to its antioxidant effects. Notably, the mechanism by which simvastatin prevents apoptosis appears to involve downregulation of H 2 O 2 -induced caspase-3 and caspase-9 activation and upregulation of Bcl-2 expression. These in vitro data suggest that simvastatin protects MG63 cells against H 2 O 2 -induced apoptosis by preventing activation of the mitochondrial pathway, thus suggesting that simvastatin may have a significant role in preventing oxidant-induced osteoporosis. However, further investigation is required to determine the upstream molecular mechanisms as well as the in vivo relevance of these observations.
